| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Letter to the Editor Re: Ahn DH, Krishna K, Blazer M, et al. “A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis.” Ther Adv Med Oncol https://doi.org/10.1177/1758834016676011
|
Von Hoff, Daniel D
|
|
2017
|
9 |
6 |
p. 441-443
|
artikel
|
| 2 |
Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications
|
Pasquali, Sandro
|
|
2017
|
9 |
6 |
p. 415-429
|
artikel
|
| 3 |
Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy
|
Ricciuti, Biagio
|
|
2017
|
9 |
6 |
p. 387-404
|
artikel
|
| 4 |
Pembrolizumab in cervical cancer: latest evidence and clinical usefulness
|
Borcoman, Edith
|
|
2017
|
9 |
6 |
p. 431-439
|
artikel
|
| 5 |
Response to Drs Von Hoff and Renschler
|
Ahn, Daniel H.
|
|
2017
|
9 |
6 |
p. 445-446
|
artikel
|
| 6 |
Review of the use of pretest probability for molecular testing in non-small cell lung cancer and overview of new mutations that may affect clinical practice
|
Martin, Petra
|
|
2017
|
9 |
6 |
p. 405-414
|
artikel
|
Tijdschrift beschrijving